glutamine and isogranulatimide

glutamine has been researched along with isogranulatimide in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (100.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Andersen, RJ; Britton, R; Jiang, X; Leong, D; Lim, LY; Piers, E; Roberge, M; Sanghera, JS; Zhao, B; Zhou, BB	1

Other Studies

1 other study(ies) available for glutamine and isogranulatimide

Article	Year
Inhibition of Chk1 by the G2 DNA damage checkpoint inhibitor isogranulatimide. Molecular cancer therapeutics, 2004, Volume: 3, Issue:10 Topics: Antineoplastic Agents; Catalytic Domain; Cell Line, Tumor; Checkpoint Kinase 1; Crystallography, X-Ray; Cysteine; DNA Damage; Dose-Response Relationship, Drug; G2 Phase; Glutamine; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Imidazoles; Indoles; Inhibitory Concentration 50; Maleimides; Models, Chemical; Models, Molecular; Nitrogen; Phenotype; Protein Binding; Protein Kinase C; Protein Kinase C beta; Protein Kinases; Protein Structure, Tertiary; Time Factors	2004

Article

Year

Inhibition of Chk1 by the G2 DNA damage checkpoint inhibitor isogranulatimide.

Molecular cancer therapeutics, 2004, Volume: 3, Issue:10

Topics: Antineoplastic Agents; Catalytic Domain; Cell Line, Tumor; Checkpoint Kinase 1; Crystallography, X-Ray; Cysteine; DNA Damage; Dose-Response Relationship, Drug; G2 Phase; Glutamine; Glycogen Synthase Kinase 3; Glycogen Synthase Kinase 3 beta; Humans; Imidazoles; Indoles; Inhibitory Concentration 50; Maleimides; Models, Chemical; Models, Molecular; Nitrogen; Phenotype; Protein Binding; Protein Kinase C; Protein Kinase C beta; Protein Kinases; Protein Structure, Tertiary; Time Factors

2004